An early assessment of Uganda’s roll-out of Option B+: Service capacity and infant outcomes

ROSE BARYAMUTUMA (1) , EDGAR KANSIIME (2) , CHARITY KYOMUGISHA NUWAGABA (3) , LINDA NABITAKA (4) , SIMON MUHUMUZA (5) , EVELYN AKELLO (6) , JOSHUA MUSINGUZI (7) , WILLIAM BAZEYO (8) , JESSICA CELENTANO (9) , CHRISTINA LINDAN3 (10)
(1) , Uganda
(2) 1Makerere University School of Public Health, Kampala, Uganda , Uganda
(3) Makerere University School of Public Health, Kampala, Uganda , Uganda
(4) AIDS Control Program, Ministry of Health, Uganda , Uganda
(5) Makerere University School of Public Health, Kampala, Uganda , Uganda
(6) Makerere University School of Public Health, Kampala, Uganda , Uganda
(7) AIDS Control Program, Ministry of Health, Uganda , Uganda
(8) Makerere University School of Public Health, Kampala, Uganda , Uganda
(9) 3Global Health Sciences, University of San Francisco, California, United States of America , United States
(10) Global Health Sciences, University of San Francisco, California, United States of America , United States

Abstract

Background: Uganda was one of the first countries in sub-Saharan Africa to implement Option B+as its national strategy for prevention-of-mother-to-child transmission (PMTCT) of HIV, doing so in 2013. We report on two evaluations designed to assess the capacity of the health care system to implement Option B+,and to obtain preliminary information on the maternal-to-child-transmission rate of HIV.


Methods: We performed: 1) a cross-sectional assessment in 2014 of 505 health care facilities (49 district hospitals, 83 Health Center [HC] IVs, and 373 HCIIIs)in 62 of Uganda’s 112 districts to evaluate whether services and commodities required for Option B+ were being provided; and 2) a retrospective record review of 283 HIV-exposed infants enrolled in post-natal care in 2013 in the Central Region to evaluate infant outcomes at 18-months of age.


Results: Less than 50% of HCIIIs performed routine diagnostics, including syphilis, hemoglobin, and urinalysis testing, required at all ante-natal clinics; almost all facilities performed a baseline CD4 cell count, but only 44.5% of HCIIIs and 60.2% of HCIVs performed follow-up testing. The proportion of facilities monitoring anti retroviral therapy (ART) (47.2-69.4%) and clinic adherence (50.0-67.3%) was low. Many facilities (20.4-45.8%) reported stock-outs of ART and HIV test kits in the prior month. At 18 months, 53.7% of HIV-exposed infants were lost to follow-up (LTFU). Among those retained, 6.5% were HIV infected.


Conclusion: Significant shortcomings in service provision and high LTFU of HIV-exposed infants are barriers to Uganda’s ability to implement Option B+ successfully.

Full text article

Generated from XML file

Authors

ROSE BARYAMUTUMA
rose.baryamutuma@gmail.com (Primary Contact)
EDGAR KANSIIME
CHARITY KYOMUGISHA NUWAGABA
LINDA NABITAKA
SIMON MUHUMUZA
EVELYN AKELLO
JOSHUA MUSINGUZI
WILLIAM BAZEYO
JESSICA CELENTANO
CHRISTINA LINDAN3
BARYAMUTUMA, R. ., KANSIIME, E., NUWAGABA, C. K., NABITAKA, L., MUHUMUZA, S., AKELLO, E., MUSINGUZI, J., BAZEYO, W., CELENTANO, J., & LINDAN3, C. (2017). An early assessment of Uganda’s roll-out of Option B+:: Service capacity and infant outcomes. Eajahme, 1(1). https://doi.org/10.58498/eajahme.v1i1.6
Copyright and license info is not available

Article Details

Most read articles by the same author(s)